tradingkey.logo

Immunoprecise Antibodies Ltd

IPA
View Detailed Chart
2.070USD
0.0000.00%
Close 02/06, 16:00ETQuotes delayed by 15 min
95.54MMarket Cap
LossP/E TTM

Immunoprecise Antibodies Ltd

2.070
0.0000.00%
Intraday
1m
30m
1h
D
W
M
D

Today

0.00%

5 Days

0.00%

1 Month

0.00%

6 Months

+9.52%

Year to Date

0.00%

1 Year

+307.48%

View Detailed Chart

TradingKey Stock Score

No stock score available due to insufficient data.

Immunoprecise Antibodies Ltd News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Immunoprecise Antibodies Ltd Info

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the IPA Family). Its Contract Research Organizations (CRO) services include B cell Select; Phage Display; DeepDisplay; Abthena Bispecifics; LucinaTech Humanization; Affinity Maturation; Immunization, hybridoma, sequencing; rPEx protein manufacturing, and Cell line development. The Company utilizes custom antigen modeling, target analysis using Natural Language Processing and the HYFTTM analysis to lay the groundwork for the subsequent experimental phases.
Ticker SymbolIPA
CompanyImmunoprecise Antibodies Ltd
CEODr. Jennifer Lynne Bath, Ph.D.
Websitehttps://www.ipatherapeutics.com/
KeyAI